{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:39:46Z","timestamp":1782963586321,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.eururo.2014.04.020","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T20:02:04Z","timestamp":1400011324000},"page":"186-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Will Active Surveillance for Clinically Localized Prostate Cancer Survive in the Era of Individualized Medicine?"],"prefix":"10.1016","volume":"66","author":[{"given":"Giorgio","family":"Gandaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.04.020_bib0005","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.6004\/jnccn.2013.0174","article-title":"Prostate cancer, version 1.2014","volume":"11","author":"Mohler","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.eururo.2014.04.020_bib0010","doi-asserted-by":"crossref","unstructured":"Haffner MC, De Marzo AM, Yegnasubramanian S, Epstein JI, Carter HB. Diagnostic challenges of clonal heterogeneity in prostate cancer. J Clin Oncol. In press. http:\/\/dx.doi.org\/10.1200\/JCO.2013.50.3540.","DOI":"10.1200\/JCO.2013.50.3540"},{"key":"10.1016\/j.eururo.2014.04.020_bib0015","doi-asserted-by":"crossref","unstructured":"Wang S, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. In press. http:\/\/dx.doi.org\/10.1111\/bju.12554.","DOI":"10.1111\/bju.12554"},{"key":"10.1016\/j.eururo.2014.04.020_bib0060","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.eururo.2014.01.027","article-title":"Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review","volume":"65","author":"van den Bergh","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.04.020_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.2010.31.4252","article-title":"Outcomes of active surveillance for men with intermediate-risk prostate cancer","volume":"29","author":"Cooperberg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.04.020_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.04.020_bib0035","doi-asserted-by":"crossref","unstructured":"Gerlinger M, Catto JW, Orntoft TF, Real FX, Zwarthoff EC, Swanton C. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2014.04.014.","DOI":"10.1016\/j.eururo.2014.04.014"},{"key":"10.1016\/j.eururo.2014.04.020_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jncimonographs\/lgs026","article-title":"Quality of life in men undergoing active surveillance for localized prostate cancer","volume":"2012","author":"Bergman","year":"2012","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.eururo.2014.04.020_bib0045","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.juro.2013.08.088","article-title":"The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance","volume":"191","author":"Ehdaie","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.04.020_bib0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-158-12-201306180-00002","article-title":"Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis","volume":"158","author":"Hayes","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2014.04.020_bib0055","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2006.10.3820","article-title":"A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer","volume":"25","author":"Walz","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814004011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814004011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T08:24:14Z","timestamp":1565425454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814004011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0302283814004011"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.020","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Will Active Surveillance for Clinically Localized Prostate Cancer Survive in the Era of Individualized Medicine?","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}